Polypectomy

The Kaiser Family Foundation, working with the American Cancer Society and the National Colorectal Cancer Round Table, today released results of its investigation into the problem of patients being billed unexpectedly for costs of colonoscopies initiated at routine screening tests. Fight Colorectal Cancer was one of the organizations that contributed to the report.

One way the new federal Affordable Care Act (ACA) aims to reduce medical spending is to improve cost-effective screening that prevents or detects diseases before they become complicated and expensive to treat.

But consumer complaints reveal that, for screening colonoscopies in particular, consumers are getting unexpected bills when insurers decide their colonoscopies were no longer “screening” procedures. Instead of providing full coverage required by the ACA federal law with no cost-sharing, patients may be charged either copayments or deductibles. Read the rest of this entry »

Ask almost anyone after their first colonoscopy, and they’ll tell you, “The procedure was nothing, but the prep was awful.”

Now patients are reporting that combining MiraLAX®, an over-the-counter laxative, with 2 quarts of Gatorade tastes better and is easier to take than the standard 4-quart Golytely colonoscopy preparation. In a randomized clinical trial , almost 100 percent said they would repeat it again, compared to 1 out of 4 who wouldn’t take GoLYTELY® in the future.

In addition, doctors found no differences in how thoroughly the two preps clean the colon.

Splitting the dose between the night before the colonoscopy and the morning of the procedure did improve colon cleansing. But there was no difference in cleansing between split-dose GoLYTELY and split-dose MiraLAX with Gatorade. Read the rest of this entry »

When patients  were offered a choice of colorectal cancer screening with either FOBT or colonoscopy, they were significantly more likely to complete that screening than when their doctors recommended only FOBT or only colonoscopy.

Nearly 1000 racially and ethnically diverse patients in urban primary care practices were randomly assigned to get colorectal cancer screening via:

• Fecal occult blood testing (FOBT)
• Colonoscopy, or
• Their choice of either FOBT or colonoscopy.

Overall, 58 percent were screened within the next year.  Read the rest of this entry »

How soon should average risk people get another colorectal cancer screening after they have a normal colonoscopy?

No sooner than 10 years, the American Gastroenterological Association recommends as part of the Choosing Wisely campaign.

The AGA’s list of Five Things Physicians and Patients Should Question includes:

1. Use the lowest possible effective dose of acid reducing medicines to treat gastroesophageal reflux disease (GERD).
2. After a negative, quality colonoscopy, don’t repeat colorectal cancer screening by any method for 10 years.
3. After removing 1 or 2 small (less than 1 centimeter) adenomatous polyps without signs of cellular change (dysplasia), don’t repeat the colonoscopy for at least 5 years.
4. After two endoscopies without dysplasia, people with Barrett’s esophagus shouldn’t have another upper endoscopy for at least 3 years.
5. Patients with abdominal pain shouldn’t have a repeat CT scan unless there are major changes in symptoms or clinical findings.

AGA’s list is based on current published recommendations for the time between colonoscopy and endoscopy in people with low risks for cancer.

The Choosing Wisely campaign wants doctors and patients to talk together about tests and treatments that are supported by evidence, don’t duplicate other tests or procedures, are free from harm, and are truly necessary.

Ask your doctor, “Do I really need this test?” and “Do I need it now?”

Seniors’ access to a screening colonoscopy is at risk and YOU can help!

We need you to continue to add your voice and urge your Representative to support H.R. 4120! Simply submit an Action Alert.

H.R. 4120, the Removing Barriers to Colorectal Cancer Screening Act of 2012, will fix a regulation that requires Medicare beneficiaries to pay coinsurance when their screening colonoscopy involves the removal of a polyp. The current policy can cost patients $100 to $300 and serve as a deterrent to screening.

We need cosponsors for this legislation if it is to pass into law & YOU can help!